COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

New Administration Creates COVID-19 Pandemic Testing Board to Coordinate National Testing Efforts

COVID-19 pandemic testing board creation
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on whatsapp
WhatsApp
Share on email
Email
Share on facebook
Share on twitter
Share on linkedin
Share on google
Share on whatsapp
Share on email

Creation of COVID-19 Pandemic Testing Board may affect clinical laboratories and lead to a change in the approach to national testing efforts

With the recent changing of presidential administrations, there has been a flurry of executive orders and changes in the approach that the new administration is using to address the COVID-19 public health emergency. While these changes will probably take weeks or months to implement, one executive order issued in the first days of the administration has the potential to directly impact clinical laboratories.

President Joe Biden signed the Executive Order on Establishing the COVID-19 Pandemic Testing Board and Ensuring a Sustainable Public Health Workforce for COVID-19 and Other Biological Threats Jan. 21, 2021. This order creates a COVID-19 Pandemic Testing Board and identifies seven key functions of the new board.

The focuses of the new COVID-19 Pandemic Testing Board will be:

  1. Coordinating federal government efforts on providing COVID-19 diagnostic, screening, and surveillance testing;
  2. Reducing disparities in testing;
  3. Identifying barriers to access to testing, especially for at-risk or vulnerable populations;
  4. Identifying methods to expand the capacity of states and other local government entities to conduct testing, contact tracing, and isolation and quarantine;
  5. Guiding the federal government’s communication about COVID-19 testing with the public;
  6. Identifying options for the federal government to maximize testing capacity of commercial labs and academic labs; and
  7. Proposing reforms to improve the federal government’s response for future pandemics or other biological emergencies.

Though much is still unknown of this new board, it may result in the development of a more coherent national testing strategy (See Lack of Coherent Testing Strategy Creates Uncertainties for Clinical Laboratories about COVID-19 Testing Volumes).

Related Resources:

White House: Executive Order on Establishing the COVID-19 Pandemic Testing Board and Ensuring a Sustainable Public Health Workforce for COVID-19 and Other Biological Threats

COVID-19 TESTING DATA

Helping Your Lab Stay Afloat During Challenging Times

Dear Colleague,

Robert L. MichelIn these challenging times for our colleagues in clinical laboratories, pathology practices and hospital administration, The Dark Intelligence Group (TDIG) — through generous grants from our partners — is bringing you the COVID-19 STAT Intelligence Briefings.

We’ve added analysts, writers and skilled editors to the COVID-19 STAT team to uncover, analyze, and immediately report to you what’s happening with the SARS-CoV-2 pandemic, packaged with the insights you need to deliver quality testing for patient care and keep your lab’s financial ship afloat. As part of our mission, we are also bringing you real-time data from our partners around testing that you will not find anywhere else.

Please let me know how we can better improve this service to fit your needs. If you would like to offer a grant to keep our mission going with this site, please contact me at rmichel@darkreport.com.

Sincerely,

Robert L. Michel
President, Founder
The Dark Intelligence Group